Through statin-based treatment, lowering LDL cholesterol did not slow kidney disease progression within five years in a study appearing in an upcoming issue of the iJournal of the American Society of Nephrology/i (JASN). The results indicate that while LDL cholesterol-lowering therapy is safe in kidney disease patients and can reduce their risk of heart disease and stroke, it does not protect their kidney health as well. Research has shown ...Sunday, 4 May 2014
LDL Cholesterol-Lowering Therapy can Reduce Risk of Heart Disease, Stroke in Kidney Disease Patients
Through statin-based treatment, lowering LDL cholesterol did not slow kidney disease progression within five years in a study appearing in an upcoming issue of the iJournal of the American Society of Nephrology/i (JASN). The results indicate that while LDL cholesterol-lowering therapy is safe in kidney disease patients and can reduce their risk of heart disease and stroke, it does not protect their kidney health as well. Research has shown ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment